European Heart Journal Advance Access originally published online on December 22, 2007
European Heart Journal 2008 29(2):144-146; doi:10.1093/eurheartj/ehm585
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
Revisiting definition and classification of cardiomyopathies in the era of molecular medicine
University of Padova Medical School, Via A. Gabelli, 61, I-35121 Padova, Italy
* Corresponding author. Tel: +39 049 8272283, Fax: +39 049 8272284, Email: gaetano.thiene@unipd.it
This editorial refers to ‘Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases’ by P. Elliott et al., on page 270
Footnotes
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
doi:10.1093/eurheartj/ehm342
| The first 150 words of the full text of this article appear below. |
Primary myocardial diseases have always attracted the attention of the scientific community because of their obscure aetiopathogenesis, and for years there was confusion and controversy regarding their nosography and taxonomy. Since the first WHO official classification,1 tremendous progress has been made.2 Novel entities have been discovered, requiring an update of the classification in 1995,3 and the aetiology of many forms has been clarified.
The Working Group of Myocardial and Pericardial Disease of the European Society of Cardiology (ESC) recently published a position statement4 different from the 2006 American Heart Association (AHA) scientific statement.5
The scope of the present editorial is to deal with the nosographic impact of the advances made since 1995 and to comment on the ESC position statement which has been designed
Revision of the definition and classification of cardiomyopathies in 1995
Understanding the molecular mechanisms of cardiomyopathies
2006 AHA scientific statement
2007 ESC position statement
Conclusions
Funding
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
- Perry Elliott, Bert Andersson, Eloisa Arbustini, Zofia Bilinska, Franco Cecchi, Philippe Charron, Olivier Dubourg, Uwe Kühl, Bernhard Maisch, William J. McKenna, Lorenzo Monserrat, Sabine Pankuweit, Claudio Rapezzi, Petar Seferovic, Luigi Tavazzi, and Andre Keren
EHJ 2008 29: 270-276.[Abstract] [FREE Full Text]
This article has been cited by other articles:
|
|
 |
|
  D. Corrado, C. Basso, A. Pelliccia, and G. Thiene CHAPTER 32 Sports and Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Galderisi The new European definition of cardiomyopathies: which space for muscle dystrophies? Eur. Heart J., June 2, 2008; 29(12): 1591 - 1592. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Elliott The 2006 American Heart Association Classification of Cardiomyopathies Is Not the Gold Standard Circ Heart Fail, May 1, 2008; 1(1): 77 - 80. [Full Text] [PDF]
|
|